LifeArc, a self-funded, non-profit medical research organisation is seeking innovative proposals to boost drug repurposing in MND by investing at least £5m in preclinical translation. The funding call is part of LifeArc’s multi-million pound MND Translational Challenge to help accelerate scientific innovation and find new treatments for people living with MND.
LifeArc will provide funding and support for researchers and SMEs who possess a repurposed drug or drug combination and a MND therapeutic target. Applicants will be required to develop project plans designed to deliver robust preclinical evidence to facilitate drug prioritization for future clinical studies in MND.
LifeArc is a hub for drug repurposing expertise and translational research (see the links to applicant resources below) and will provide successful applicants with advice and mentorship as well as access to a collaborative network of potential project partners to enable the best chance of project success. Its track record in drug repurposing is extensive and it will work closely with all funding recipients throughout the lifecycle of the project to help support the individual project needs.
Submission of a completed Expression of Interest form is required as part of the application process. Please visit the LifeArc links below for more information about this funding call.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.